Todos Medical Ltd. (TOMDF)

Overview

Todos Medical Ltd. is an in vitro diagnostics company focused on developing and bringing to market blood tests for the early detection of cancer and Alzheimer's disease in the United States. Leveraging proprietary technologies, such as Total Biochemical Infrared Analysis and Lymphocyte Proliferation Test, the company aims to advance cancer screening and the diagnosis of neurodegenerative disorders. Incorporated in 2010 and based in Tel Aviv, Israel, Todos Medical has engaged in collaboration agreements with Integrated Health LLC and other companies to expand its testing capabilities, including screening for SARS-nCoV-2 and distributing COVID-19 test kits. Through its innovative approach to diagnostics, Todos Medical Ltd. seeks to significantly impact how diseases are detected and managed, offering new avenues for early intervention.

Products and Services

• Total Biochemical Infrared Analysis (TBIA)

  A proprietary technology developed for cancer screening using peripheral blood spectroscopy analysis. This method aims to explore how cancer affects the immune system, providing a non-invasive and innovative approach to cancer detection.

• Lymphocyte Proliferation Test (LPT)

  A diagnostic blood test designed to measure the ability of peripheral blood lymphocytes and monocytes to respond to exogenous mitogenic stimulation, which is crucial for understanding the body's immune response and potential cancer developments.

• Neurodegenerative Disorders Blood Tests

  These blood tests focus on the detection of neurodegenerative disorders, such as Alzheimer's disease, offering a potential for early diagnosis and management of such conditions.

• TM-B1 and TM-B2

  Specifically designed for breast cancer testing, these products are part of Todos Medical's cancer screening and diagnosis range, offering innovative options for early detection.

• TMC Blood Test

  A targeted test for the screening and diagnosis of colon cancer, providing a crucial tool in the fight against one of the most common types of cancer.

• Tollovid

  A 3CL protease inhibitor dietary supplement intended to support healthy immune function, particularly against circulating coronaviruses. This product highlights Todos Medical's diversification into supporting general immune health amidst the global pandemic.

• Tollovir

  An antiviral treatment for COVID-19, currently in Phase 2 clinical trials. Tollovir represents Todos Medical's foray into therapeutic interventions against the coronavirus, emphasizing the company's commitment to contributing solutions during the pandemic.